Prevalence and Impact of Treatment Crossover in Cardiac Surgery Randomized Trials: A Meta‐Epidemiologic Study

Author:

Gaudino Mario1,Fremes Stephen E.2,Ruel Marc3,Di Franco Antonino1,Di Mauro Michele4,Chikwe Joanna56,Frati Giacomo78,Girardi Leonard N.1,Taggart David P.9,Biondi‐Zoccai Giuseppe710

Affiliation:

1. Department of Cardiothoracic Surgery Weill Cornell Medicine New York NY

2. Schulich Heart Centre Division of Cardiac Surgery Department of Surgery Sunnybrook Health Sciences Centre University of Toronto Ontario Canada

3. University of Ottawa Heart Institute University of Ottawa Ontario Canada

4. Heart Department SS Annunziata Hospital Chieti Italy

5. Department of Cardiothoracic Surgery Stony Brook School of Medicine New York NY

6. Department of Cardiothoracic Surgery Mount Sinai Hospital New York NY

7. Department of Medico‐Surgical Sciences and Biotechnologies Sapienza University of Rome Latina Italy

8. Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S.) Neuromed Pozzilli Italy

9. Nuffield Department of Surgical Sciences University of Oxford United Kingdom

10. Mediterranea Cardiocentro Napoli Italy

Abstract

Background Crossover dilutes treatment effect and reduces statistical power of intention‐to‐treat analysis. We examined incidence and impact on cardiac surgery randomized controlled trial ( RCT ) outcomes of crossover from experimental to control interventions, or vice versa. Methods and Results MEDLINE , EMBASE , and Cochrane Library were searched, and RCT s (≥100 patients) comparing ≥2 adult cardiac surgical interventions were included. Crossover from the initial treatment assignment and relative risks ( RRs ) for each trial's primary end point and mortality at longest available follow‐up were extracted. All RR s were calculated as >1 favored control group and <1 favored experimental arm. Primary outcome was the effect estimate for primary end point of each RCT , and secondary outcome was all‐cause mortality; both were appraised as RR at the longest follow‐up available. Sixty articles reporting on 47 RCT s (25 440 patients) were identified. Median crossover rate from experimental to control group was 7.0% (first quartile, 2.0%; third quartile, 9.7%), whereas from control to experimental group, the rate was 1.3% (first quartile, 0%; third quartile, 3.6%). RR s for primary end point and mortality were higher in RCT s with higher crossover rate from experimental to control group ( RR , 1.01 [95% CI , 0.94–1.07] versus RR , 0.80 [95% CI , 0.66–0.97] and RR , 1.02 [95% CI , 0.95–1.11] versus RR , 0.94 [95% CI , 0.82–1.07], respectively). Crossover from control to experimental group did not alter effect estimates for primary end point or mortality ( RR , 0.82 [95% CI , 0.63–1.05] versus RR , 0.95 [95% CI , 0.86–1.04] and RR , 0.88 [95% CI , 0.73–1.07] versus RR , 1.02 [95% CI , 0.95–1.09], respectively). Conclusions Crossover from experimental to control group is associated with outcomes of cardiac surgery RCT s. Crossover should be minimized at designing stage and carefully appraised after study completion.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3